MARTELL RON
SEC insider (Form 3/4/5 filer). CIK 0001177079. President, CEO and Director at Jasper Therapeutics, Inc. (JSPR). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in REDWOOD CITY, CA.
Companies MARTELL RON has filed insider reports for
- Jasper Therapeutics, Inc. (JSPR): Director, Officer, President, CEO and Director
MARTELL RON
CIK: 0001177079
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Jasper Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
234K shares- - Sep 22, 2025JSPR
Jasper Therapeutics, Inc.
PurchaseDirect41K shares at avg. $2.43$100K - Jun 4, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
234K shares- - Feb 13, 2025JSPR
Jasper Therapeutics, Inc.
AwardDirectStock Option (right to buy)
130K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 234,000 | - | - | Direct |
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | Purchase | 41,000 | $2.43 | $99,630 | Direct |
| Jun 4, 2025 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 234,000 | - | - | Direct |
| Feb 13, 2025 | JSPR Jasper Therapeutics, Inc. | Award Stock Option (right to buy) | 130,000 | - | - | Direct |
1-4 of 4 transactions